newheader.jpg
 


Conference Menu

Overview
Day 1
Day 2
Day 3
Register
PDF Download
Sponsor/Exhibit
Hotel & Travel
Poster
Press Pass
Request Brochure
Send to a Colleague
 

Suggest a Topic
for Tech Talks

 
Corporate Sponsor:
 
Lead Sponsoring
Publication:
 
Sponsoring
Publication:
 
Sponsoring
Society:
 

Web Partners:


Demand for genomic and gene expression analysis continues. However, nucleic acid isolation and purification is one of the most technically challenging and labor-intensive procedures performed in any laboratory, whether for biodefense, drug discovery, or diagnostics. Whatever technology is selected, success depends on a balanced combination of good experimental design, sample preparation, primer/probe design, amplification, detection, and analysis, as well as the selection of equipment and reagents. New technical developments that improve the performance of nucleic acid amplification and detection, as well as practical examples of how these techniques are used, continues as the emphasis of Cambridge Healthtech Institute's 14th Annual Nucleic Acid-Based Technologies meeting. Learn from savvy, seasoned researchers as they share their experiences with their latest technologies and cutting edge results.

KEYNOTE PRESENTATION:
Dr. Brian D. Harfe, Department of Molecular Genetics & Microbiology, University of Florida College of Medicine

     Sessions Include:

The $6 Million Solution: Creating Higher Throughput
• Thinking Outside the Box: Emerging Nucleic Acid
    Techniques
• Detection of Pathogens and Biothreats
• Detection of Microbial Nucleic Acid in Blood and
   Biologics
• miRNAs: Approaches, Applications and Analysis

PLUS

• In Depth Coverage: Rapid Microbial Detection
• Networking Roundtable Discussions
• Technology Watch Focus
• Interactive Panel Discussions
• See Who’s Who & What’s New in the Exhibit Hall

Learn from savvy, seasoned researchers as they share their experiences with their latest technologies and cutting-edge results.

Dr. Carl Wittwer, Professor, Pathology,
University of Utah

Dr. Klaus-Stefan Drese, Fluidic and
Simulation, Institut für Mikrotechnik Mainz GmbH

Mr. Thomas Peterson, Director of
Engineering, IQuum, Inc.

Dr. Michael Hogan,Managing Director,
Scientific Affairs, Argylla Technologies LLC

Dr. Huimin Kong, President, BioHelix
Corporation

Dr. Richard Yuqi Zhao, Associate Professor of Pathology, Microbiology-Immunology & Human Virology, University of Maryland School of Medicine; Director, Molecular Diagnostics Laboratory, University of Maryland Medical Center

Dr. Fubao Wang, Vaccine and Biologics
Research, Merck & Co., Inc.

Dr. Fred Russell Kramer, Chairman,
Department of Molecular Genetics,
The Public Health Research Institute,
Newark, New Jersey

Dr. David A. Roth, Senior Vice President,
Research and Development, Phoenix
Biomolecular Corporation

Dr. Susan D. Cohen, President, Center for
Regulatory Research, LLC

Mr. Kevin Hall, Engineer, Remediation
Technologies Division, North Wind, Inc.

Dr. Natasha Paul, Staff Scientist,
Research and Development, TriLink
Biotechnologies, Inc.

Dr. Syed Hashsham, Associate Professor, Civil and Environmental Engineering, Michigan State University

Dr. Steve Kornguth, Director, Center for
Strategic and Innovative Technologies, The University of Texas at Austin

Dr. Susan W. Jones, MFS, Collection Scientist, Bacteriology, American Type Culture Collection/BEI Resources

Dr. Matt Aldissi, President, Senior Staff
Scientist, Fractal Systems, Inc.

Dr. Xing Wang, Senior Principal Scientist,
Global Biologics, Pfizer, Inc.

Dr. Daniel P. Kolk,
Associate Director, Research and
Development, Gen Probe Incorporated

Dr. Jeanne Jordan, Associate Professor,
Pathology, University of Pittsburgh, Magee-Women’s Hospital and Research Institute

Dr. Michael Reed, Director, R&D,
Blood CellStorage , Inc. and Owner,
BioConjugate Consulting

Dr. A. Selvapandiyan, Division of Emerging and Transfusion Transmitted Disease, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration

Dr. Ronald P. Hart, Associate Director and Member, W.M. Keck Center for Collaborative Neuroscience; Professor, Rutgers University

Dr. Shih-Peng Chan, Postdoctoral Fellow,
Department of Molecular, Cellular and
Developmental Biology, Yale University


foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |
Health-IT World
| Bio-IT World Conference & Expo  | Molecular Medicine Tri-Conference | PEGS| PepTalk | Pharma DD
World Pharmaceutical Congress |

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com